COVID-19 Vaccine Efficacy After First Dose: Pfizer, Moderna, AstraZeneca
New data about Pfizer COVID-19 efficacy after the first dose suggests high efficacy, raising questions about potential alternative dosing schedules.
All articles by Chen Fang, PharmD, RPh
But Is it Fair? Bioethics, COVID-19 Vaccine Distribution, and Advocacy
We speak with Mildred Solomon, EdD, President of the Hastings Center and Professor of Global Health and Social Medicine at Harvard Medical School, where she directs the school’s Fellowship in Bioethics, about the COVID-19 pandemic, health equity, and vaccine distribution.
ENSEMBLE Trial: J&J COVID-19 Vaccine Phase 3 Interim Analysis
Johnson & Johnson released interim analysis of its phase 3 EMSEMBLE trial for Ad.26.COV2, and provided more insight on overall protection in various countries, variant protection, and clinical outcomes.
Regaining Public Trust in Science: Conversation With Dr Fauci
Anthony Fauci, MD, discusses public trust in science, vaccine progress, and vaccine facilitation as the United States heads toward a new phase of the pandemic.
COVID-19: What Now, What’s Next?
George Abraham, MD, offers insight into where the United States currently stands with regard to the COVID-19 pandemic, vaccine development, barriers to care in various patient populations, and the evolving roles of infectious disease specialists.
- Loading...
Loading...
Next post in General Neurology
Loading... 
Loading...